- €2.60bn
- €2.72bn
- €2.19bn
- 94
- 51
- 100
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,631 | 1,386 | 1,462 | 1,766 | 2,187 |
Cost of Revenue | |||||
Gross Profit | 977 | 866 | 876 | 1,044 | 1,368 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,606 | 1,367 | 1,401 | 1,673 | 1,935 |
Operating Profit | 25.6 | 19.8 | 60.3 | 93 | 252 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -23 | -46.8 | 59.5 | 86.5 | 219 |
Provision for Income Taxes | |||||
Net Income After Taxes | -36.8 | -72 | 62.5 | 79.3 | 257 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -108 | -174 | 71.1 | 74.1 | 255 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -108 | -174 | 71.1 | 74.1 | 255 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.089 | -1.08 | 0.535 | 0.709 | 2.16 |
Dividends per Share |